Molecular Characterization of the Vasculature of Patients with Infiltrating Ductal Carcinoma Generates a Gene Signature Predictive of Breast Cancer Survival

@inproceedings{Le2015MolecularCO,
  title={Molecular Characterization of the Vasculature of Patients with Infiltrating Ductal Carcinoma Generates a Gene Signature Predictive of Breast Cancer Survival},
  author={Phuong Uyen Le and Jie Li and Christiane Cantin and Catherine Collins and Andr{\'e} Nantel and Tammy-Lynn Tremblay and John F Kelly and Edwin Wang and Maureen D. O’Connor-McCourt and Anne E. G. Lenferink},
  year={2015}
}
Targeting of the tumor vasculature has evolved into an integral part of existing standard anti-cancer therapies. However, recent pre-clinical and clinical studies have shown that the efficacy of these treatments is often temporary and frequently followed by renewed tumor growth. In an attempt to overcome this problem we transcriptionally profiled laser capture micro dissected micro vessels from both tumor and matching adjacent normal breast tissue obtained from patients diagnosed with… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 78 REFERENCES

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

Yi Zhang, Anieta M. Sieuwerts, +17 authors John A. Foekens
  • Breast Cancer Research and Treatment
  • 2008
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2005
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

464-478

Alitalo K. Molecular regulation of angiogenesis Adams RH, lymphangiogenesis. Nat Rev Mol Cell Biol. 2007
  • Central Lenferink et al. (2015) Email: J Cancer Biol Res 3(3): 1068
  • 2015
VIEW 1 EXCERPT

835680

Pagès G. Molecular mechanisms of resistance to tumour an Grépin R, 2010
  • Central Lenferink et al. (2015) Email: J Cancer Biol Res 3(3): 1068
  • 2015
VIEW 1 EXCERPT

an overview of the randomised trials

Polychemotherapy for early breast cancer
  • Early Breast Cancer Trialists’ Collaborative Group. Lancet. 1998; 352: 930-942. Le PU, Li J, Cantin C, Collins C, Nantel A, et al.
  • 2015
VIEW 1 EXCERPT